New oral contraceptive

January 1997

Parke-Davis will soon introduce a new oral contraceptive...the 21-day Estrostep, and the 28-day Estrostep FE.

Estrostep is a "triphasic" pill with increasing doses of ESTROGEN...and a fixed dose of progestin.

It provides 20 mcg of ethinyl estradiol for 5 days...30 mcg for 7 days...then 35 mcg for the last 9 days.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Discussions about MedGuides are heating up
Alzheimer's Disease New Alzheimer's drug, Aricept (donepezil)
Alzheimer's Disease Drugs that help PREVENT Alzheimer's
Dermatology A new prescription antifungal cream
Diabetes Rezulin (REZ-u-lin, troglitazone), for Type II diabetes
Diabetes Accu-Check InstantPlus, the first home monitor for both glucose and cholesterol
Diabetes Computer software programs for diabetics
Prozac (fluoxetine) for bulimia
Antifungals Fungizone (amphotericin B) ORAL suspension
Antifungals Two LIPID formulations of IV amphotericin B...Abelcet
Women's Health Common symptom of menopause is oral discomfort
Cardiology Two new COMBINATION antihypertensives
Cardiology Several alternatives for patients who get a chronic cough from ACE inhibitors
Cardiology Beta blockers to reduce the risk of heart attack or heart failure after surgery
Contraceptives New oral contraceptive
Contraceptives Closer look at vaginal spermicides
Thrombolytics New thrombolytic, Retavase (reteplase)
Asthma Zyflo (zileuton) for asthma
Practice Chart of significant new drugs approved in 1996